are bpc-157 and tb-500 fda approved The meets on peptides starting tomorrow. Seven compounds — BPC-157, KPV, TB-500, MOTS-c, DSIP, Semax, Epitalon — go before the compounding advisory committee July 23–24. It's not a drug approval. It's TB 500 vs BPC 157:

AOD-9604 is a short synthetic peptide fragment designed for experimental research involving growth hormonerelated signaling mechanisms

Skip alcohol 24 hours before your appointment

Minimized Damage to the skin surface: Unlike laser skin resurfacing, Fractional Radio Frequency is able to deliver the energy where its needed most, in the lower dermis, while minimizing the damage to the skins surface

AOD 9604 is typically used during fasted states and is compatible with intermittent fasting protocols

The trial was registered with the Iranian Registry of Clinical Trials on 25/12/2019 ( registered code: IRCT20120718010333N5)